Literature DB >> 2657848

CT of the stomach and duodenum.

J C Scatarige1, D J DiSantis.   

Abstract

CT has become an important tool in the diagnosis and management of diseases that affect the stomach and duodenum. By depicting the bowel lumen, wall, and extramural structures, CT can provide unique information that complements standard air contrast radiography and endoscopy. Proper scanning methods and knowledge of normal anatomy are necessary for optimal results. We utilize the gas contrast technique for organ-specific examination in patients with known or suspected gastroduodenal disease. Gastric adenocarcinoma is an important indication for CT evaluation. Unfortunately, early hopes that CT could accurately stage gastric cancer have not been realized. CT is not as accurate as laparotomy in staging early gastric cancer, primarily owing to its inability to detect small peritoneal implants, diagnose metastases in normal-sized lymph perigastric nodes, and predict pancreatic invasion. Nevertheless, CT retains an important role in depicting gross metastatic disease and guiding percutaneous biopsy, particularly in patients who are deemed poor surgical candidates or have undergone prior gastric resection. A variety of conditions other than primary gastric adenocarcinoma produce recognizable abnormalities on CT. Gastric lipoma, leiomyosarcoma, and varices have a distinctive appearance. Others, including gastritis and uncomplicated peptic ulcer, produce nonspecific gastric wall thickening. Endoscopic correlation and biopsy are required for specific diagnosis in these cases. The duodenum, by virtue of its location in the anterior pararenal compartment of the retroperitoneum, may be involved by numerous benign and malignant conditions. In blunt trauma, complicated pancreatitis, and peptic ulcer disease, as well as primary and metastatic malignancy, CT can provide data that may alter patient management.

Entities:  

Mesh:

Year:  1989        PMID: 2657848

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  8 in total

1.  Evaluation of contrast-enhanced helical hydro-CT in staging gastric cancer.

Authors:  Wen-Zhou Wei; Jie-Ping Yu; Jun Li; Chang-Sheng Liu; Xiao-Hua Zheng
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

Review 2.  Using computed tomography scans to develop an ex-vivo gastric model.

Authors:  Jerome A Henry; Gerard O'Sullivan; Abhay S Pandit
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

3.  The role of gallium 67 imaging in non-Hodgkin's lymphoma of the gastrointestinal tract.

Authors:  M Kataoka; M Kawamura; T Tsuda; H Itoh; A Komatsu; S Tanada; A Iio; K Hamamoto
Journal:  Eur J Nucl Med       Date:  1990

4.  A preoperative assessment of adjacent organ invasion by stomach carcinoma with high resolution computed tomography.

Authors:  A Tsuburaya; Y Noguchi; A Matsumoto; S Kobayashi; K Masukawa; K Horiguchi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  Diagnostic difficulties with duodenal malignancies revisited: a new strategy.

Authors:  W Cwikiel; A Andrén-Sandberg
Journal:  Gastrointest Radiol       Date:  1991

6.  Determination of the relationship between gastric wall thickness and body mass index with endoscopic ultrasound.

Authors:  Michael C Larsen; Brian M Yan; John Morton; Jacques Van Dam
Journal:  Obes Surg       Date:  2009-04-18       Impact factor: 4.129

7.  CT findings of gallbladder metastases: emphasis on differences according to primary tumors.

Authors:  Won Seok Choi; Se Hyung Kim; Eun Sun Lee; Kyoung-Bun Lee; Won Jae Yoon; Cheong-Il Shin; Joon Koo Han
Journal:  Korean J Radiol       Date:  2014-04-29       Impact factor: 3.500

8.  Significance of Gastric Wall Thickening Detected in Abdominal CT Scan to Predict Gastric Malignancy.

Authors:  A Akbas; H Bakir; M F Dasiran; H Dagmura; Z Ozmen; N Yildiz Celtek; E Daldal; O Demir; A Kefeli; I Okan
Journal:  J Oncol       Date:  2019-11-20       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.